Latest news & articles

Latest news
IAA trial: abatacept combined with nasal insulin in recently diagnosed type 1 diabetes

IAA trial: abatacept combined with nasal insulin in recently diagnosed type 1 diabetes

IAA (Insulin And Abatacept) is a randomised controlled trial testing whether the combination of two safe disease-modifying therapies called abatacept and nasal insulin slows down the immune attack on the insulin-producing (beta) cells of people with newly-diagnosed type 1 diabetes. Abatacept is a disease-modifying medication approved for treatment of rheumatoid arthritis in both adults and […]
Social value of health gains

Social value of health gains

If you were allocating money for health treatment and care, would it be different for children or young people compared to adults? We are looking to interview young people aged 15 years old. We are interested in your views on how decisions about funding medicines and health services should be made. This will assist policy […]
Making friends with yourself: Self-compassion for young people with type 1 diabetes

Making friends with yourself: Self-compassion for young people with type 1 diabetes

Our researchers are recruiting young Australians between the ages of 14 and 17, who are diagnosed with Type 1 Diabetes and who are using continuous glucose monitoring. The course consists of 8 x 1.5-hour group sessions.  The first session is scheduled for Wednesday 30th March 2022. Sessions will be delivered via Zoom and take place […]
Managing type 1 diabetes during exercise in high-level athletes

Managing type 1 diabetes during exercise in high-level athletes

Regular exercise is a cornerstone for managing type 1 diabetes (T1D), but many people with T1D face obstacles that stop them meeting physical activity guidelines. However, athletes with T1D are highly proficient at managing their condition within the context of their sport. For this reason, their strategies may offer valuable lessons for managing blood glucose […]
Fenofibrate and microvascular events in type 1 diabetic retinopathy (FAME-1-EYE) study
Uncategorised

Fenofibrate and microvascular events in type 1 diabetic retinopathy (FAME-1-EYE) study

This clinical trial is investigating whether fenofibrate, a drug used to lower cholesterol, can slow or reverse eye damage in adults with type 1 diabetes. Fenofibrate has been shown to slow eye damage in type 2 diabetes, and researchers are now investigating whether the same effect will be seen in T1D. This study has been […]
Type1Screen: Screening for type 1 diabetes
Uncategorised

Type1Screen: Screening for type 1 diabetes

Family members of people with T1D are at increased risk of developing the disease themselves. Type1Screen is a free screening service available to any family member of a person with T1D, that can find out a person’s risk of developing T1D. Those at increased risk will be offered the opportunity to enrol in trials of […]